- INJ rose 10.24% as the first CFTC-regulated futures debuted on Bitnomial Exchange.
- April Community BuyBack removed 51K INJ (~$156K), a 4% increase over March.
- Chartist confirmed a descending wedge breakout with a 98% measured-move target.
- Injective now sits alongside BTC, ETH, SOL, and XRP in the U.S.-regulated futures market.
Injective price is up 10.24% over the past 24 hours, trading around $3.30 after the first regulated INJ futures contracts went live on Bitnomial, a CFTC-designated contract market.
Derivatives volume spiked 91.75% to $120.10M, open interest climbed 27.47% to $62.01M, and shorts bore the brunt of the move, with $81.96K in short positions being liquidated over 24 hours against just $32.82K on the long side.
The Wednesday launch puts Injective coin in a small bracket alongside Bitcoin, Ethereum, Solana, and XRP as digital assets with a regulated U.S. derivatives footprint.
Bitnomial Lists INJ as CFTC Futures Debut Alongside BTC and ETH
The Bitnomial listing is the clearest institutional signal INJ has received in this market cycle. Contracts are crypto-settled with monthly expirations, allowing traders to post digital assets or USD as margin through Bitnomial Clearinghouse, LLC, a capital-efficiency edge that cash-only venues can’t replicate. Access now runs through FCMs for institutional clients, with retail exposure coming through Bitnomial’s Botanical platform in the coming weeks.
Bitnomial President Michael Dunn pointed to Injective’s on-chain order book, cross-chain execution, and near-zero gas fees as the core investment thesis, and flagged that CFTC-listed futures could serve as a building block toward a spot ETF under the SEC’s generic listing standards.
That framing matters, as Canary Capital has already filed with the SEC for a staked INJ ETF, and the precedent from BTC and ETH suggests regulated futures are typically a prerequisite before spot approval moves.
Injective co-founder Eric Chen called the Bitnomial listing a validation of demand for institutional-grade access, noting the broader goal of drawing a wider range of market participants into the network.
Separately, Injective completed its April Community BuyBack, removing 51,000 INJ (~$156,000) from circulation, a 4% increase over March’s 49,000 INJ burn.
Injective Price Breaks a Year-Long Descending Wedge
On the daily chart, analyst World Of Charts flagged a confirmed breakout from a multi-month descending wedge that had been compressing Injective coin since its all-time high of $52.75 in March 2024, a structure that had enforced consistently lower highs across 2025 and into early 2026.
The measured move from the wedge base targets a 98% extension above the breakout level, projecting near-term upside into the $5–$6 range based on the charted setup.
Intraday, buyers stepped in off the $2.99 session low and drove the price to a high of $3.41 before settling near $3.30. The rejection at the top suggests overhead resistance is still present, but volume behind the move limits the immediate reversal case.
For the Injective price prediction picture, the technical and fundamental setups are aligned in the same direction simultaneously, including regulated market access, active supply reduction, and a structural breakout in a single session.
Bitnomial has indicated perpetual futures and options are next on the roadmap. Whether those products attract the volume to hold the breakout range through May is the operative question.
READ MORE: Chiliz Coin Targets $0.40 After Breaking 5-Year Downtrend
